Fatal neurological disease in scrapie-infected mice induced for experimental autoimmune encephalomyelitis

Yael Friedman-Levi1, Haim Ovadia, Romana Hoftberger

  • 1Department of Neurology, Hadassah University Hospital, Jerusalem, Israel.

Journal of Virology
|July 13, 2007
PubMed

Insights

Inflammation during prion disease incubation accelerates neurological decline. Co-infection with autoimmune conditions significantly shortens survival, highlighting the clinical impact of central nervous system inflammation in prion diseases.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Prion diseases have long incubation periods where individuals may experience other health issues.
  • The impact of concurrent infections or inflammatory conditions on prion disease progression is unknown.

Purpose of the Study:

  • To investigate how experimental autoimmune encephalomyelitis (EAE), a model of CNS inflammation, affects scrapie prion disease progression in mice.
  • To elucidate the mechanisms underlying any observed changes in disease course.

Main Methods:

  • Mice were infected with the scrapie agent and subsequently induced with EAE.
  • Biochemical and pathological markers of both prion disease and EAE were analyzed.
  • Prion protein (PrPSc) levels, inflammatory markers (demyelination, gliosis, immune cell infiltration), and PrPSc deposition were evaluated.

Main Results:

  • Mice co-induced with EAE died significantly earlier than control scrapie-infected mice.
  • PrPSc levels in the brain and spleen were similar to asymptomatic scrapie-infected mice, indicating the co-induced disease was not accelerated scrapie.
  • Markedly increased inflammatory markers, including demyelination and gliosis, were observed in the spinal cords of co-induced mice.
  • PrPSc depositions were found in demyelinated areas, suggesting prion neuroinvasion facilitated by infiltrating immune cells.

Conclusions:

  • Inflammatory processes, particularly within the central nervous system, can severely impact individuals incubating prion diseases.
  • Concurrent inflammation may not accelerate prion replication but can lead to a more rapid and severe clinical presentation.
  • These findings suggest a critical interplay between the immune system and prion pathogenesis.